Clinical trial Recruiting at 1 site Interventional Ages 18 to 75

Using brain stimulation to improve memory in older adults with mild cognitive impairment

Official title: Adaptive Neuromodulation of Working Memory Networks in Aging and Dementia

Run by Indiana University · NCT05460468 · Data updated 2026-11-12

This study is testing if a special brain stimulation technique can help older adults with mild cognitive impairment improve their memory.

Quick facts

Study typeInterventional
Ages18 Years to 75 Years
SexAll
Enrollment150 (estimated)
SponsorIndiana University
Academic / other
Locations1 site (Durham, North Carolina)
StatusRecruiting
StartedMarch 28, 2024
Main results expectedJune 30, 2027
Study endsJune 30, 2027
Registry record updatedAugust 11, 2026
Trial IDNCT05460468 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are English-speaking older adults with mild cognitive impairment who are willing to provide consent.

Probably not a fit

Patients with significant neurological disorders or those at increased risk of seizures may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research aims to enhance working memory in older adults and those with mild cognitive impairment (MCI) through closed-loop transcranial magnetic stimulation (TMS) targeted at the prefrontal cortex. The study will investigate how individualized brain networks can be used to optimize TMS parameters for better control of brain states. By measuring the effects of TMS on working memory performance and neural activity, the researchers hope to establish a reliable method for improving cognitive function in these populations. The approach addresses previous limitations in TMS efficacy by considering dynamic cognitive states and the influence of cerebrovascular health.

Why it matters

Potential benefit: If successful, this approach could lead to improved memory function and quality of life for patients with mild cognitive impairment.

How similar studies have gone: While some studies have shown promise in using TMS for cognitive enhancement, this specific closed-loop approach tailored to individual brain networks is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* English Speaking
* Willing to provide consent

Exclusion Criteria:

* History of any Axis I DSM-V disorder, excluding major depressive disorder or generalized anxiety disorders
* Current history of substance abuse or dependence (excluding nicotine)
* Intracranial implants (e.g. aneurysms clips, shunts, stimulators, cochlear implants, or electrodes), cardiac pacemakers, or vagus Nerve stimulation device
* Increased risk of seizure for any reason, including prior diagnosis of epilepsy, seizure disorder, increased intracranial pressure, or history of significant head trauma with loss of consciousness for ≥ 5 minutes.
* Neurological disorder including, but not limited to: space occupying brain lesion; any history of seizures, history of cerebrovascular accident; fainting, cerebral aneurysm, Dementia, Hungtington chorea; Multiple Sclerosis.
* Current use of medications known to lower the seizure threshold and/or affect working memory

Where it's running

  • Duke University Hospital
    Durham, North Carolina, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.